Induction of hepatic 11β‐hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease
Authors:
- 19 November 2007
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 68 (6) , 898-903
Abstract
Summary: Background and aim The alcohol‐induced pseudo‐Cushing's syndrome is an important differential diagnosis of hypercortisolism that is poorly understood. Two isozymes of 11β‐hydroxysteroid dehydrogenase (11β‐HSD) interconvert hormonally active cortisol (F) and inactive cortisone (E). Previously we have shown higher urinary F : E metabolite ratios (a reflection of global 11β‐HSD activity) in patients with alcoholic liver disease (ALD) compared to patients with chronic liver disease (CLD) of other aetiologies, suggesting that the phenotype of alcoholic pseudo‐Cushing's may relate to altered metabolism of F.Subjects and methods We performed selective venous sampling of the hepatic, renal and peripheral veins measuring F and E concentrations (using in‐house radioimmunoassay) in 20 patients with histologically confirmed ALD and 19 patients with CLD. Six patients who also had selective venous sampling for investigation of suspected hyperaldosteronism were used as ‘normal’ controls.Results There was a significant difference in the hepatic F gradient (mean ± SEM) between groups, indicating increased F production in the liver in patients with ALD (34·5 ± 21·7 nmol/l) compared to those with CLD (–21·0 ± 18·5 nmol/l) (P < 0·05) and normals (–19·7 ± 17·2 nmol/l) (P < 0·05). 11β‐HSD1 mRNA expression was increased fivefold in the ALD group compared with normal controls (P < 0·01).Conclusions These results indicate significant induction of HSD11B1 gene expression and activity in patients with ALD during short‐ and long‐term abstinence from alcohol. The mechanism is unknown but might be explained on the basis of alcohol‐induced changes in intracellular redox potential or as a protective mechanism to limit liver inflammation and injury. Selective 11β‐HSD1 inhibitors may offer a novel therapeutic approach to treat alcoholic pseudo‐Cushing's.Keywords
This publication has 25 references indexed in Scilit:
- Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose TissueRecent Progress in Hormone Research, 2004
- Modulation of 11β-Hydroxysteroid Dehydrogenase Isozymes by Proinflammatory Cytokines in Osteoblasts: An Autocrine Switch from Glucocorticoid Inactivation to ActivationJournal of Bone and Mineral Research, 2001
- On the mechanism of alcohol-induced pseudo-Cushing's syndromeEndocrine Reviews, 1996
- The short-chain alcohol dehydrogenase superfamily: Variations on a common themeThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.Journal of Clinical Investigation, 1993
- Alcohol-induced pseudo-Cushing's syndromeThe Lancet, 1993
- 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver diseaseThe Journal of Clinical Endocrinology & Metabolism, 1993
- Mineralocorticoid excess and inhibition of 11 β‐hydroxysteroid dehydrogenase in patients with ectopic ACTH syndromeClinical Endocrinology, 1992
- THE KIDNEY IS THE MAJOR SITE OF CORTISONE PRODUCTION IN MANClinical Endocrinology, 1989
- Mechanism for Selective Perivenular Hepatotoxicity of EthanolAlcohol, Clinical and Experimental Research, 1982